Risky assets jump on another vaccine news
Stock markets experienced a big jump while gold plunged after Moderna announced results of the interim analysis of phase 3 trial of its coronavirus vaccine. Moderna said that its vaccine has shown 94.5% efficiency. This is higher than 90% efficiency of the Pfizer/BioNTech vaccine announced last week. Analysis has met required statistical criteria. Vaccine developed by Moderna can also be stored for longer than one from Pfizer making logistics easier. Company plans to file for an emergency use authorization in the United States in the coming weeks.
Markets seem to like the news with a big boost to riskier assets. DE30 jumped 100 points on the news while US500 gained around 20 points. Gold slumped around $25 and USDJPY jumped from 104.50 to 105.00.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile app
DE30 tests resistance zone at 13,250 pts following announcement from Moderna. Source: xStation5
